That is not the EMA's role. A simple Google search explains:
The EMA's primary responsibility is to evaluate the safety, quality, and efficacy of medicines based on scientific data submitted in marketing authorization applications.
The EMA does not consider factors related to a company's financial resources, like cash on hand, when assessing a drug's suitability for marketing authorization.